Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4515648
Max Phase: Preclinical
Molecular Formula: C40H51N7O8
Molecular Weight: 757.89
Molecule Type: Unknown
Associated Items:
ID: ALA4515648
Max Phase: Preclinical
Molecular Formula: C40H51N7O8
Molecular Weight: 757.89
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ccc(NC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H]2COC(=O)[C@@H]3C[C@H](C)CN3C(=O)[C@H](C)NC(=O)[C@@H]3CCCCN3C(=O)[C@@H]3CCCN3C2=O)cc1
Standard InChI: InChI=1S/C40H51N7O8/c1-24-14-16-28(17-15-24)42-40(54)44-29(21-27-10-5-4-6-11-27)34(48)43-30-23-55-39(53)33-20-25(2)22-47(33)36(50)26(3)41-35(49)31-12-7-8-18-45(31)38(52)32-13-9-19-46(32)37(30)51/h4-6,10-11,14-17,25-26,29-33H,7-9,12-13,18-23H2,1-3H3,(H,41,49)(H,43,48)(H2,42,44,54)/t25-,26-,29-,30-,31-,32-,33-/m0/s1
Standard InChI Key: CFCNKBNDWQNSIO-MRHHCFRNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 757.89 | Molecular Weight (Monoisotopic): 757.3799 | AlogP: 1.88 | #Rotatable Bonds: 6 |
Polar Surface Area: 186.56 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 15 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.14 | CX Basic pKa: | CX LogP: 1.88 | CX LogD: 1.88 |
Aromatic Rings: 2 | Heavy Atoms: 55 | QED Weighted: 0.32 | Np Likeness Score: -0.05 |
1. (2018) Substituted urea depsipeptide analogs as activators of the clpp endopeptidase, |
Source(1):